- Home
- HCKT vs RXST Comparison
HCKT vs RXST Comparison
Compare HCKT & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCKT | RXST |
|---|---|---|
| Founded | 1991 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 300.5M |
| IPO Year | 1998 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HCKT | RXST |
|---|---|---|
| Price | $10.16 | $6.33 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 10 |
| Target Price | ★ $17.00 | $9.78 |
| AVG Volume (30 Days) | 408.6K | ★ 618.2K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $285,862,000.00 | $134,479,000.00 |
| Revenue This Year | $2.55 | N/A |
| Revenue Next Year | $5.07 | $10.06 |
| P/E Ratio | $58.88 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.16 | $5.30 |
| 52 Week High | $25.97 | $16.47 |
Technical Indicators
Market Signals| Indicator | HCKT | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 40.21 | 48.51 |
| Support Level | $9.16 | $5.90 |
| Resistance Level | $14.49 | $7.60 |
| Average True Range (ATR) | 0.70 | 0.37 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 21.87 | 48.40 |
Price Performance
Historical ComparisonAbout HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.